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Background: Fractional flow reserve (FFR) is an established invasive method for assessing the physiological significance of intermediate coronary 
artery stenoses (ICAS). Regadenoson, a selective A2A receptor agonist, is a hyperemic agent used for pharmacological stress imaging, but its role for 
measuring FFR is unknown.
Methods: This prospective single center study enrolled 19 consecutive patients with an ICAS discovered during elective angiography. In each 
patient, FFR of the ICAS was measured first by IV adenosine (140 μg/kg/min) followed by IV regadenoson (400 μg bolus). The correlation between 
FFR with adenosine and regadenoson was evaluated. 
Results: The mean age was 63±12 years, and mean LVEF was 57±11%. Most patients were female (53%), had hypertension (84%) and 
dyslipidemia (89%), with 26% having diabetes mellitus and 21% COPD. The ICAS was visually estimated during angiography (mean 59±10%) and 
most often found in the left anterior descending (53%). There was a strong correlation between the FFR measured with adenosine compared to 
regadenoson (r=0.985, P<0.001) [Fig]. A hemodynamically significant lesion (FFR<0.80) was present in 58% with no reclassification of significance 
between adenosine and regadenoson. No major adverse events occurred with administration of either drug.
Conclusion: Our results suggest that a single IV bolus of regadenoson is as effective as an IV infusion of adenosine for measuring FFR, and given 
its ease of use, should be considered for FFR measurement in the cath lab.
